Pregnancy, delivery, and outcome for the child in maternal epilepsy

Epilepsia

Volumn 50, Issue 9, 2009, Pages 2130-2139

  Veiby, Gyri ^a,b   Daltveit, Anne K ^a,c   Engelsen, Bernt A ^a,b   Gilhus, Nils E ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Antiepileptic drugs; Congenital malformations; Epilepsy; Neonatal outcome; Pregnancy

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; ETIRACETAM; FOLIC ACID; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ADULT; APGAR SCORE; ARTICLE; BIRTH WEIGHT; CESAREAN SECTION; CHILD; CONGENITAL MALFORMATION; CONTROLLED STUDY; DELIVERY; EPILEPSY; FEMALE; HEAD CIRCUMFERENCE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL EPILEPSY; MONOTHERAPY; NORWAY; OUTCOME ASSESSMENT; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PREMATURE LABOR; PRIORITY JOURNAL; REGISTER; RISK FACTOR; SMALL FOR DATE INFANT; SPINA BIFIDA; VITAMIN SUPPLEMENTATION;

ABNORMALITIES, DRUG-INDUCED; ADULT; ANTICONVULSANTS; APGAR SCORE; BIRTH WEIGHT; CONGENITAL ABNORMALITIES; EPILEPSY; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; MATERNAL AGE; MATERNAL EXPOSURE; MATERNAL-FETAL EXCHANGE; NORWAY; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RISK FACTORS; VALPROIC ACID;

EID: 69149088182     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2009.02147.x     Document Type: Article

References (46)

1. Adab N, Kini U, Vinten J, Ayres J, Baker G, Clayton-Smith J, Coyle H, Fryer A, Gorry J, Gregg J, Mawer G, Nicolaides P, Pickering L, Tunnicliffe L, Chadwick DW 2004) The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 75 : 1575 1583.
2. Artama M, Auvinen A, Raudaskoski T, Isojarvi I, Isojarvi J 2005) Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology 64 : 1874 1878.
3. Bjerkedal T, Bahna SL 1973) The course and outcome of pregnancy in women with epilepsy. Acta Obstet Gynecol Scand 52 : 245 248.
4. Botto LD, Lisi A, Robert-Gnansia E, Erickson JD, Vollset SE, Mastroiacovo P, Botting B, Cocchi G, de Vigan C, de Walle H, Feijoo M, Irgens LM, McDonnell B, Merlob P, Ritvanen A, Scarano G, Siffel C, Metneki J, Stoll C, Smithells R, Goujard J. (2005) International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working? BMJ 330 : 571.
5. Breen DP, Davenport RJ 2006) Teratogenicity of antiepileptic drugs. BMJ 333 : 615 616.
6. Crawford P 2001) CPD-Education and self-assessment: epilepsy and pregnancy. Seizure 10 : 212 219.
7. Cunnington M, Tennis P 2005) Lamotrigine and the risk of malformations in pregnancy. Neurology 64 : 955 960.
8. Czeizel AE, Dudas I 1992) Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327 : 1832 1835.
9. Dolk H, Jentink J, Loane M, Morris J, de Jong-van den Berg LT 2008) Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations? Neurology 71 : 714 722.
10. Eeg-Olofsson O, Chen MF, Andermann E, Dansky L, Guyda HJ, Kinch RA 1990) Evaluation of placental morphology and growth factor receptors in women receiving antiepileptic drugs: a pilot study. Epilepsia 31 : 446 452.
11. Gaulden ME 1992) Maternal age effect: the enigma of down syndrome and other trisomic conditions. Mutat Res 296 : 69 88.
12. Hiilesmaa VK, Bardy A, Teramo K 1985) Obstetric outcome in women with epilepsy. Am J Obstet Gynecol 152 : 499 504.
13. Hoff JM, Daltveit AK, Gilhus NE 2007) Myasthenia gravis in pregnancy and birth: identifying risk factors, optimising care. Eur J Neurol 14 : 38 43.
14. Holmes LB, Harvey EA, Coull BA, Huntington KB, Khoshbin S, Hayes AM, Ryan LM 2001) The teratogenicity of anticonvulsant drugs. N Engl J Med 344 : 1132 1138.
15. Holmes LB, Baldwin EJ, Smith CR, Habecker E, Glassman L, Wong SL, Wyszynski DF 2008) Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy. Neurology 70 : 2152 2158.
16. Irgens LM 2002) Medical birth registry - an essential resource in perinatal medical research. Tidsskr Nor Laegeforen 122 : 2546 2549.
17. Jelliffe-Pawlowski LL, Hansen RL 2004) Neurodevelopmental outcome at 8 months and 4 years among infants born full-term small-for-gestational-age. J Perinatol 24 : 505 514.
18. Kaaja E, Kaaja R, Matila R, Hiilesmaa V 2002) Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate. Neurology 58 : 549 553.
19. Kalviainen R, Tomson T 2006) Optimizing treatment of epilepsy during pregnancy. Neurology 67 : S59 S63.
20. Kampman MT 2007) Folate status in women of childbearing age with epilepsy. Epilepsy Res 75 : 52 56.
21. LaJoie J, Moshe SL 2004) Effects of seizures and their treatment on fetal brain. Epilepsia 45 (Suppl 8 48 52.
22. Mastroiacovo P, Bertollini R, Licata D 1988) Fetal growth in the offspring of epileptic women: results of an Italian multicentric cohort study. Acta Neurol Scand 78 : 110 114.
23. Meador KJ, Baker GA, Finnell RH, Kalayjian LA, Liporace JD, Loring DW, Mawer G, Pennell PB, Smith JC, Wolff MC 2006) In utero antiepileptic drug exposure: fetal death and malformations. Neurology 67 : 407 412.
24. Morrow J, Russell A, Guthrie E, Parsons L, Robertson I, Waddell R, Irwin B, McGivern RC, Morrison PJ, Craig J 2006) Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 77 : 193 198.
25. Moster D, Lie RT, Markestad T 2002) Joint association of Apgar scores and early neonatal symptoms with minor disabilities at school age. Arch Dis Child Fetal Neonatal Ed 86 : F16 F21.
26. Nilsen RM, Vollset SE, Gjessing HK, Magnus P, Meltzer HM, Haugen M, Ueland PM 2006) Patterns and predictors of folic acid supplement use among pregnant women: the Norwegian Mother and Child Cohort Study. Am J Clin Nutr 84 : 1134 1141.
27. O'Keeffe MJ, O'Callaghan M, Williams GM, Najman JM, Bor W 2003) Learning, cognitive, and attentional problems in adolescents born small for gestational age. Pediatrics 112 : 301 307.
28. Pallotto EK, Kilbride HW 2006) Perinatal outcome and later implications of intrauterine growth restriction. Clin Obstet Gynecol 49 : 257 269.
29. Pennell PB 2004) Pregnancy in women who have epilepsy. Neurol Clin 22 : 799 820.
30. Pennell PB 2006) 2005 AES annual course: evidence used to treat women with epilepsy. Epilepsia 47 (Suppl 1 46 53.
31. Perucca E 2005) Birth defects after prenatal exposure to antiepileptic drugs. Lancet Neurol 4 : 781 786.
32. Pilo C, Wide K, Winbladh B 2006) Pregnancy, delivery, and neonatal complications after treatment with antiepileptic drugs. Acta Obstet Gynecol Scand 85 : 643 646.
33. Rosa FW 1991) Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med 324 : 674 677.
34. Sabers A, Dam M, Rogvi-Hansen B, Boas J, Sidenius P, Laue FM, Alving J, Dahl M, Ankerhus J, Mouritzen DA 2004) Epilepsy and pregnancy: lamotrigine as main drug used. Acta Neurol Scand 109 : 9 13.
35. Samren EB, van Duijn CM, Christiaens GC, Hofman A, Lindhout D 1999) Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol 46 : 739 746.
36. Sherer DM, Anyaegbunam A, Onyeije C 1998) Antepartum fetal intracranial hemorrhage, predisposing factors and prenatal sonography: a review. Am J Perinatol 15 : 431 441.
37. Sherman SL, Allen EG, Bean LH, Freeman SB 2007) Epidemiology of Down syndrome. Ment Retard Dev Disabil Res Rev 13 : 221 227.
38. Skjaerven R, Gjessing HK, Bakketeig LS 2000) Birthweight by gestational age in Norway. Acta Obstet Gynecol Scand 79 : 440 449.
39. Skomsvoll J, Ostensen M, Baste V, Irgens L 2002) Validity of a rheumatic disease diagnosis in the Medical Birth Registry of Norway. Acta Obstet Gynecol Scand 81 : 831 834. (Pubitemid 35026058)
40. Vajda FJ, Eadie MJ 2005) Maternal valproate dosage and foetal malformations. Acta Neurol Scand 112 : 137 143.
41. Vajda FJ, Hitchcock A, Graham J, Solinas C, O'Brien TJ, Lander CM, Eadie MJ 2006) Foetal malformations and seizure control: 52 months data of the Australian Pregnancy Registry. Eur J Neurol 13 : 645 654.
42. Viinikainen K, Heinonen S, Eriksson K, Kalviainen R 2006) Community-based, prospective, controlled study of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy. Epilepsia 47 : 186 192.
43. Vrachnis N, Botsis D, Iliodromiti Z 2006) The fetus that is small for gestational age. Ann N Y Acad Sci 1092 : 304 309.
44. Wide K, Winbladh B, Kallen B 2004) Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study. Acta Paediatr 93 : 174 176.
45. Wyszynski DF, Nambisan M, Surve T, Alsdorf RM, Smith CR, Holmes LB 2005) Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology 64 : 961 965.
46. Yerby M, Koepsell T, Daling J 1985) Pregnancy complications and outcomes in a cohort of women with epilepsy. Epilepsia 26 : 631 635.